[{"address1": "1177 Avenue of the Americas", "address2": "5th floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "332 216 1147", "website": "https://sunshinebiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals. It operates through Generic Pharmaceuticals and OTC Products segments. The company is developing Adva-27a, a Topoisomerase II inhibitor to treat aggressive forms of cancer, as well as multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; SBFM-PL4, a protease inhibitor for the treatment of SARS Coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; L-Citrulline; Taurine. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant use. Sunshine Biopharma, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 44, "companyOfficers": [{"maxAge": 1, "name": "Mr. Camille  Sebaaly", "age": 64, "title": "CFO & Secretary", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abderrazzak  Merzouki", "age": 59, "title": "Chief Science Officer & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 340000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steve N. Slilaty Ph.D.", "age": 71, "title": "CEO, President & Chairman", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 430000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Beaudoin", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Malek  Chamoun", "age": 38, "title": "Chief Development Officer", "yearBorn": 1985, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Ferreira", "age": 61, "title": "President of Sunshine Bio Investments Inc", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.8584, "open": 0.84, "dayLow": 0.82, "dayHigh": 1.03, "regularMarketPreviousClose": 0.8584, "regularMarketOpen": 0.84, "regularMarketDayLow": 0.82, "regularMarketDayHigh": 1.03, "beta": -1.105, "forwardPE": 0.05147059, "volume": 7324048, "regularMarketVolume": 7324048, "averageVolume": 1901487, "averageVolume10days": 10109990, "averageDailyVolume10Day": 10109990, "marketCap": 870212, "fiftyTwoWeekLow": 0.75, "fiftyTwoWeekHigh": 140.0, "priceToSalesTrailing12Months": 0.03611919, "fiftyDayAverage": 5.7131, "twoHundredDayAverage": 25.879774, "currency": "USD", "enterpriseValue": -14763429, "profitMargins": -0.18702999, "floatShares": 953395, "sharesOutstanding": 994528, "sharesShort": 69800, "sharesShortPriorMonth": 9709, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.070199996, "heldPercentInsiders": 0.094510004, "heldPercentInstitutions": 0.065120004, "shortRatio": 0.28, "shortPercentOfFloat": 0.0732, "impliedSharesOutstanding": 1100650, "bookValue": 75.671, "priceToBook": 0.0115632145, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -4506044, "trailingEps": -19.0, "forwardEps": 17.0, "lastSplitFactor": "1:100", "lastSplitDate": 1713312000, "enterpriseToRevenue": -0.613, "enterpriseToEbitda": 3.184, "52WeekChange": -0.9853434, "SandP52WeekChange": 0.23099434, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SBFM", "underlyingSymbol": "SBFM", "shortName": "Sunshine Biopharma Inc.", "longName": "Sunshine Biopharma, Inc.", "firstTradeDateEpochUtc": 1644935400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7909c686-ce8d-3dd2-8c10-62221258e4a3", "messageBoardId": "finmb_78729055", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.875, "targetHighPrice": 300.0, "targetLowPrice": 300.0, "targetMeanPrice": 300.0, "targetMedianPrice": 300.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 16292347, "totalCashPerShare": 16.382, "ebitda": -4636152, "totalDebt": 657705, "quickRatio": 3.394, "currentRatio": 4.483, "totalRevenue": 24092788, "debtToEquity": 3.101, "revenuePerShare": 99.017, "returnOnAssets": -0.10569999, "returnOnEquity": -0.21039, "freeCashflow": -8202214, "operatingCashflow": -8775111, "revenueGrowth": 0.949, "grossMargins": 0.34612998, "ebitdaMargins": -0.19243, "operatingMargins": -0.15458, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-01"}]